Tuberculosis

Nutra Pharma Announces Breakthrough with Rapid Tuberculosis Test Kit Technology

Published in TB and Outbreaks Week, June 19th, 2007

Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that its medical devices division, Designer Diagnostics, has developed a rapid diagnostic test kit for Tuberculosis and will be conducting clinical trials at National Jewish Hospital in Denver, Colorado.

"With the recent scare out there of XDR-TB and MDR-TB, we believe that our test kit technology will help contribute to limiting the spread of the Tuberculosis around the world," explained Rik J Deitsch, Chairman of Nutra Pharma Corp. "We are working closely with world renowned researchers, Dr. Charles Daley and Dr. Leonid Heifets, at National...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2007-06-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry